IRF4 Gene Rearrangements Define a Subgroup of CD30-Positive Cutaneous T-Cell Lymphoma: A Study of 54 Cases

This publication has 39 references indexed in Scilit:

• Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders
  British Journal of Dermatology, 2009
• Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge
  Leukemia, 2008
• The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children
  Blood, 2007
• The development of inflammatory TH-17 cells requires interferon-regulatory factor 4
  Nature Immunology, 2007
• Molecular Diagnosis of Burkitt's Lymphoma
  New England Journal of Medicine, 2006
• A suggested protocol for obtaining high-quality skin metaphases from primary cutaneous T-cell lymphoma
  Cancer Genetics and Cytogenetics, 2006
• Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment
  Blood, 2000
• A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells
  Blood, 2000
• Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis
  Blood, 1998
• Characterization of t(2;5) Reciprocal Transcripts and Genomic Breakpoints in CD30+ Cutaneous Lymphoproliferations
  Blood, 1998